Fundraising FoxBioStar Ventures
Venture capitalPetoskey · Growth · 14 people tracked
Find your way into BioStar Ventures
Sign up to see every warm intro you have to BioStar Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioStar Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
BioStar Capital leverages a distinctive team of healthcare clinicians, medical thought leaders, and financial professionals to identify and support medical technology ventures. The firm focuses on companies that can deliver both patient impact and strong financial returns for investors.
Source: firm website, verified Sep 20, 2026.
Team · 14 people
from the firm's website & curated & public directories
What they invest in
from 11 of 12 portfolio companiesHealthtech ×8Biotech ×4Medical Devices ×3Fintech ×2Advanced Manufacturing ×1Cybersecurity ×1Deep Tech ×1Developer Tools ×1
HQs:United States×11
Investments · 12 tracked
founders shown can be your intro pathBy year:2017 · 12015 · 32014 · 15 dated
Autonomix is developing a catheter-based platform that senses nerve activity in real time and performs targeted transvascular denervation, allowing physicians to map, ablate, and verify nerve signaling during a procedure.
Deep TechHealthtechMedical DevicesThe Woodlands, US
David Robins(Director)Robert Schwartz(Executive Officer)inLandy Toth(Chief Technology Officer)Matthew Lourie(Executive Officer)Robert Van Tassel(Executive Officer)Brad Hauser(Chief Executive Officer and President)in
HealthtechWakefield, US
Tim A. Fischell(Executive Officer, Director)inKate Rumrill(Executive Officer, Director)Lisa Mastromattei(Executive Officer)Ronald D Bache(Executive Officer, Director)Vartan E. Ghazarossian(Executive Officer, Director)David R. Fischell(Director)
Co-investorsMichigan Capital NetworkGilde HealthcareMAF
BiotechHealthtechSt. Paul, US
Joshua Woolley(Executive Officer)inRyan Gladney(Executive Officer)Gary Graham(Executive Officer)Dan W. Gladney(Executive Officer, Director)inPeter DeLange(Executive Officer)inBruce A. Machmeier(Executive Officer)
Co-investorsAngel Physicians FundBrightstone Venture CapitalBroadview VenturesCatalyst Health VenturesPortfoliaXeraya Capital
Ellipse World develops payment card and smartcard technology aimed at reducing fraud and making digital payments safer for the financial industry and e-commerce.
CybersecurityFintechHardwareCulver City, US
Cyril Lalo(CEO & Founder)inSebastien Pochic(Chief Technology Officer)inGabrielle Levy(Chief Financial Officer)inMike Gaffney(President)inJacques Essebag(Director)
Co-investorsTrousdale VenturesUpfront Ventures
Foldax develops heart valve replacement technology leveraging polymer expertise and biologic design.
Advanced ManufacturingBiotechHealthtechMedical DevicesSalt Lake City, US
Frank Maguire(Executive Officer, Director)
BoardKen Charhut(Director)George Wallace(Director)Morteza Gharib(Director)Mory Gharib(Director)
Co-investorsAngel Physicians FundKairos Venture Investments, LlcMemorialCare Innovation FundBioStar CapitalKairos Venture PartnersSUMMATION HEALTH VENTURES
Trice provides real-time payment processing through an embedded API that enables businesses to receive funds instantly without chargeback or reversal concerns.
Developer ToolsFintechSaaS
Doug Yeager(CEO)in
Co-investorsLightspeed Venture PartnersDiagramFINTOP CapitalGaingelsHealthQuest Capital
__Twitter.png)
Trice Medical develops minimally invasive medical devices, including ultrasonic tenotomy systems for percutaneous tissue removal (treating tendinopathy, calcific tendonitis, and bone spurs), endoscopic carpal tunnel and ligament release systems, diabetic foot ulcer procedure tools, and portable high-resolution arthroscopy.
BiotechHealthtechMedical DevicesMalvern, US
Jeffrey O'Donnell(Executive Officer, Director)Mark Foster(Executive Officer, Director)inRichard Kienzle(Executive Officer, Director)in
BoardAlan Davis(Director)Randy Scott(Director)inGary Kurtzman(Director)
Co-investorsHealthQuest Capital
HealthtechSunnyvale, US
John Pavlidis(Executive Officer, Director)Michael Horzewski(Executive Officer, Director)Michael Pederson(Executive Officer, Director)
BoardDavid McIntyre(Director)Justin Klein(Director)Sami Hamade(Director)
Co-investorsNew Enterprise Associates (NEA)Windham Capital Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Corindus Vascular RoboticsConventus OrthopaedicsEllipse TechnologiesKona Medical
Exits · 1
1 IPOsAutonomix MedicalNASDAQ: AMIX
Portfolio news
latest coverage across their companiesIPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Autonomix Medical | 10.5% | $6.54 | Nov 2024 | $790.1K |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Public market activity · per SEC filings
what is this? ⓘDisclosed stake · filed Oct 2024
2 insider ownership filings (Forms 3/4/5)
at Autonomix Medical, Inc. (AMIX)
From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.
Frequently asked questions
- How many investments has BioStar Ventures made?
- BioStar Ventures has 12 tracked investments, 1 of which have exited.
- What stage does BioStar Ventures invest at?
- BioStar Ventures invests at the Growth stage.
- What sectors does BioStar Ventures focus on?
- BioStar Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is BioStar Ventures located?
- BioStar Ventures is headquartered in Petoskey, US.
Co-investors · 1
Broadview Ventures is an impact investor focused on accelerating the development of technology for the diagnosis and treatment of cardiovascular disease and stroke through targeted investments.
Firms observed investing alongside BioStar Ventures, from public investor directories. Shared companies are the overlap with BioStar Ventures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.